Ustekinumab and Vedolizumab Dual Biologic Therapy in the Treatment of Crohn’s Disease
We present a case of refractory ileocolonic Crohn’s disease in a 27-year-old female treated with dual ustekinumab and vedolizumab biologic therapy. She had mucosal healing for the first time in 13 years after a 10-month treatment of ustekinumab overlapped with 6 months of vedolizumab. No side effect...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2017-01-01
|
| coleção: | Case Reports in Medicine |
| Acesso em linha: | http://dx.doi.org/10.1155/2017/5264216 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|